Tag: #UNMCHIV

Publication Alert: Structural Vulnerability among Patients with HIV and SARS-CoV-2 Co-Infection

Publication Alert: Structural Vulnerability among Patients with HIV and SARS-CoV-2 Co-Infection. This content was provided by Natasha Hongsermeier-Graves, MD/MPH student at UNMC College of Medicine/Harvard School of Public Health. She led a recently published study, collaborating with another UNMC medical student Rohan Khazanchi, and UNMC ID faculty Drs. Jasmine Marcelin and Nada Fadul.

Oct 19, 2021

Freedom is in the Air: My Visit to Sudan, a Born-again Country

Here at UNMC ID, we are thrilled to share the global, and personal efforts, of our faculty. Please take a moment to read this excellent piece by Dr. Nada Fadul; Associate Professor, Division of Infectious Diseases, UNMC Sudan felt different this time. It was the middle of December 2019, the first anniversary of the Sudanese […]

Feb 25, 2020

PharmToExamTable: What do we know about Etravirine for HIV?

Recently, several of our HIV pharmacist colleagues in our Division of Infectious Diseases at UNMC/Nebraska Medicine, published an invited review in Clinical Pharmacokinetics entitled: Clinical Pharmacokinetics and Pharmacodynamics of Etravirine: An Updated Review.  The first author, Dr. Josh Havens PharmD, wrote this summary describing the review article. What prompted the review? This was an invited […]

Dec 17, 2019

Following up on pharmacist-led HIV pre-exposure prophylaxis

Earlier this year we featured a study by UNMC ID Drs. Sara Bares and Susan Swindells: “Midwest pharmacists’ familiarity, experience, and willingness to provide pre-exposure prophylaxis (PrEP) for HIV.”  We’re excited to share an update on their work building inter-professional relationships to increase PrEP education and use in Nebraska that was recently published in Open Forum […]

Dec 6, 2019

Medical Student Musings from #UNMCHIV2019

This year, the UNMC HIV Update for Care Providers and Educators on October 10, 2019 brought approximately 100 attendees to Omaha again to learn about new drugs, management approaches, and patient experiences with HIV. The CME conference was funded by the Nebraska AIDS Education & Training Center (AETC), [a local partner of the Midwest AETC], and […]

Oct 30, 2019

Everyone Should be Tested for HIV

Today is National HIV Testing Day, and one of the most fulfilling conversations to have with persons living with HIV (PLWH) is to share that since the 1980’s, we have made significant progress in the management of the AIDS epidemic. FDA approval of 27 antiretrovirals and 20 fixed dose combination antiretrovirals, increased HIV testing campaigns and […]

Jun 27, 2019

Nadal Fadul, MD on Why I Love ID

Why I love ID and UNMC: The strong commitment to serving the community, the great opportunities provided to faculty; and my former colleague, Salman Ashraf, who is very happy here!  I chose ID because my passion is taking care of people living with HIV, however, I enjoy all of ID and the intellectual challenge it […]

May 14, 2019

Inter-Professional Relationships in HIV Pre-exposure Prophylaxis

We’re excited to feature a recent publication borne from student-faculty collaboration that highlights the importance of interdisciplinary care! Dr. Jordan Broekhuis, the lead author, is one of our former HIV Enhanced Medical Education Track (EMET) students who is now a surgery resident at Beth Israel Deaconess.  He completed his EMET work here at UNMC under […]

Apr 18, 2019

UNMC Division of Infectious Diseases – New Faculty Announcement

The Division of Infectious Diseases is pleased to announce the arrival of our newest Faculty members! Nada Fadul, MD Dr. Fadul will be supporting UNMC’s efforts on various Ryan White awards through the Specialty Care Center, where she will also serve as the Associate Medical Director. In addition, Dr. Fadul will support the General ID […]

Oct 22, 2018

Pharm to Exam Table: Doravirine DRIVES the way to more ART options

The Department of Health and Human Services HIV guidelines panel currently recommends antiretroviral therapy (ART) consisting of two nucleoside reverse transcriptase inhibitors plus an integrase inhibitor for most treatment naïve HIV infected individuals1.  Prior to the advent of integrase inhibitors, the utilization of non-nucleoside reverse transcriptase inhibitor (NNRTI) based regimens had been common.   Both efavirenz […]

Oct 15, 2018